OxTalks is Changing
During Michaelmas Term, OxTalks will be moving to a new platform (full details are available on the Staff Gateway).
For now, continue using the current page and event submission process (freeze period dates to be advised).
If you have any questions, please contact halo@digital.ox.ac.uk
The Hypoxia Paradox: Friend or Foe for T cell Cancer Therapies?
Iosifina Foskolou, PhD, is a group leader at Sanquin Institute (Amsterdam), specialising in T cell metabolism and cancer immunotherapy. Her lab focuses on improving T cell immunotherapies against solid tumours by better understanding the environments immune cells face in both the tumour microenvironment and lymphoid tissues.
Iosifina holds a DPhil in Oncology from the University of Oxford, where she studied the effects of low oxygen (hypoxia) in solid tumours. She has extensive postdoctoral experience at both Cambridge University and the Karolinska Institute, where she investigated how metabolism can improve cancer immunotherapy.
Iosifina has a robust academic background, and her work has been widely published in peer-reviewed journals, with key papers on T cell function, metabolism, and anti-tumour immunity. Throughout her career, she has secured numerous grants, including a Marie Sklodowska Curie post-doctoral Fellowship.
Date:
31 July 2024, 12:00
Venue:
Old Road Campus Research Building, room 71a/b/c
Speaker:
Dr Iosifina Foskolou (Sanquin Institute (Amsterdam))
Organising department:
Department of Oncology
Organiser:
Yuliia Karpenko
Organiser contact email address:
adminsupport@oncology.ox.ac.uk
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Yuliia Karpenko
